Position in ESPR
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$445
+$445 QoQ
Shares Held
141
+101.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 40 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GAMMA Investing LLC holds $6,662,328 across 41 Drug Manufacturers - Specialty & Generic names. ESPR ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,769 | $958,497 | |
| 2 | ZTS |
Zoetis Inc.
|
12,047 | $865,697 | |
| 3 | VTRS |
Viatris Inc
|
43,632 | $692,876 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
3,714 | $625,957 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,361 | $384,910 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,348 | $371,427 | |
| 7 | ALKS |
Alkermes plc.
|
6,705 | $351,308 | |
| 8 | HLN |
Haleon plc
|
34,810 | $324,777 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $445 | 141 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | — | 70 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | — | 523 | Shares | Defined | 2026-01-05 | |
| No filing history on record for this holder in this stock. | ||||||